Ken Stern & Associates’s AbbVie ABBV Stock Holding History

Ken Stern & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$665K	Buy	7,027 +1	+0%	+$95	0.29%	47
2018 Q2	$651K	Buy	7,026 +57	+0.8%	+$5.57K	0.3%	38
2018 Q1	$660K	Sell	6,969 -44	-0.6%	-$4.83K	0.29%	34
2017 Q4	$678K	Sell	7,013 -57	-0.8%	-$5.37K	0.3%	37
2017 Q3	$630K	Sell	7,070 -133	-2%	-$10.1K	0.28%	39
2017 Q2	$520K	Buy	7,203 +1	+0%	+$67	0.24%	49
2017 Q1	$475K	Sell	7,202 -59	-0.8%	-$3.71K	0.22%	54
2016 Q4	$455K	Sell	7,261 -56	-0.8%	-$3.42K	0.24%	57
2016 Q3	$462K	Buy	7,317 +1	+0%	+$65	0.32%	46
2016 Q2	$453K	Buy	7,316 +99	+1%	+$6.03K	0.36%	43
2016 Q1	$412K	Buy	7,217 +1,350	+23%	+$75.2K	0.29%	46
2015 Q4	$348K	Buy	5,867 +17	+0.3%	+$979	0.23%	61
2015 Q3	$318K	Buy	5,850 +802	+16%	+$52.2K	0.25%	53
2015 Q2	$339K	Buy	5,048 +523	+12%	+$34.1K	0.25%	42
2015 Q1	$465K	Buy	+4,525	New	+$273K	0.35%	40

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ken Stern & Associates's ABBV Position: Q3 2018 in Review

Ken Stern & Associates increased its AbbVie (ABBV) stake by 0.01% in Q3 2018, buying an estimated $95 and bringing the position to 7,027 shares worth $665K. The position accounts for 0.29% of the portfolio, ranked #47.

Ken Stern & Associates first reported a position in ABBV in Q1 2015 and has held it in 15 quarters since. The position peaked at $678K in Q4 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Ken Stern & Associates held 7,027 shares of AbbVie worth $665K as of Q3 2018.
Ken Stern & Associates bought 1 AbbVie share in Q3 2018, an estimated $95.
AbbVie made up 0.29% of Ken Stern & Associates's portfolio in Q3 2018, its #47 holding.
Ken Stern & Associates first reported a position in AbbVie in Q1 2015 and has held it in 15 quarters since.
Ken Stern & Associates's AbbVie position peaked at $678K in Q4 2017.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.